Kaplan-Meier Plotter survival analysis suggested that breast cancer patients with low expression of USP53 had significantly worse overall survival (OS, Fig. 2D) and relapse free survival (RFS, Fig. 2E) than those with high expression. The gene discussed is USP53; the disease is breast cancer.